Odyssey Therapeutics Statistics
NASDAQ: ODTXHealthcareBiotechnologyUSD
18.08-0.05 (-0.28%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Odyssey Therapeutics by the numbers
Odyssey Therapeutics has a market capitalization of $868.9 million based on 48.06M shares outstanding. With trailing EPS of $-7.53, Odyssey Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.9% below its 50-day average and 9.2% below its 200-day average.
Average daily trading volume is 271.02K shares, or about $4.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ODTX valuation vs. peer median
| Metric | ODTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $868.90M | $875.72M | -1% |
| Avg. volume | 271.02K | 929.04K | -71% |
Peer median across 8 companies: GLUE, CRVS, JBIO, ALMS, SLBT, RIGL, ARDX, ANL.
Valuation
- Market cap
- $868.90M
- EPS (TTM)
- $-7.53
- Shares outstanding
- 48.06M
Price and trading
- Previous close
- 18.13
- Open
- 18.01
- Day range
- 17.83 – 18.84
- 52-week range
- 15.10 – 29.05
- Beta
- —
- Volume
- 264.07K
- Average volume
- 271.02K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 868.90M
- Forward Pe
- -4.15
- Eps
- -7.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 29.05
- Week52 Low
- 15.10
- Avg Volume
- 271.02K
- Shares Outstanding
- 48.06M
- Ma50
- 22.56
- Ma200
- 19.91
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -37.76%
- Pct From52w Low
- 19.74%